Here is information concerning Don’s question.
You really only need to take about 4,000 units to get the benefit - but only after you get your doctor to get a base reading of your Vitamin D levels, possible less.
Vitamin D Lowers Risk of Atherosclerosis in Diabetes Patients
www.biotechdaily.com/therapeutics/articles/294725251/vitamin_d_lowers_risk_of_atherosclerosis_in_diabetes_patients.htmlVitamin D: Vitamin D optimizes calcium metabolism and starts reversing the calcium deposits (plaque) on your artery walls.
www.mnwelldir.org/docs/cardio/cardio9.htmYou might want to read:
Dr. Fuster is the world’s leading heart cardiologist and researcher:
mountsinaihospital.net/profiles/valentin-fusterDr Valentin Fuster, MD, PhD (director of cardiovascular research at Mount and Professor of Cardiology at Sinai School of Medicine in New York and previous head of the American Heart Association) published the results of a forty-year study (from 1959 to 1999) in a book called Understanding Vulnerable Plaque.
Fuster talks about a marker called c-reactive protein, causing the inflammation.
Even Newsweek eventually picked up the story quoting Dr Fuster: “inflammation in the circulating blood may play an important role in triggering heart attacks by activating blood clotting mechanisms.” Fuster even has the integrity to state that the role of physicians should be to care for the blood and not go into the plumbing business (performing expensive “roto-rooter” services on our blood vessels).
If you go to Dr Garry Gordon’s web site,
www.gordonresearch.com, you’ll see that Dr Gordon was pushing this line of thought years before it was released in the Wall Street Journal. You’ll see that for the past ten years Dr Garry Gordon has not sent one of his heart disease patients in for bypass surgery. You’ll see that he has written all sorts of papers on Bypassing Bypass Surgery:
And check out this supplement Wobenzym and another one called superZlite Zeolite,
Make sure it is superZlite, other brands are inferior.
Wobenzym® is an enzyme preparation initially developed in Germany in the 1960’s by the Medical Enzyme Research Foundation.
Wobenzym® is backed by millions of dollars of research. This research has been primarily done in Europe, there are FDA approved studies under way in the United States on Osteo-Arthritis and Multiple Myeloma.
Studies in Europe have documented an average lowering of C-reactive protein levels (a marker of chronic infection in the body) of 30%.